Skip to content
About
About ImmixBio
Management
Board of Directors
Scientific Advisory Board
Hear From The Team
Technology
Pipeline
Overview
Publications
Investors & News
Overview
IMMX Milestone Day April 2022
Press Releases
In The News
Events & Presentations
IMMX Investors Day
Stock Info
SEC Filings
Documents and Charters
Committees
Investor FAQ
Contact IR
Email Alerts
Contact
Immix Biopharma, Inc - Tissue-Specific Therapeutics (TSTx) Targeting Oncology & Immuno-Dysregulated Diseases
About
About ImmixBio
Management
Board of Directors
Scientific Advisory Board
Hear From The Team
Technology
Pipeline
Overview
Publications
Investors & News
Overview
IMMX Milestone Day April 2022
Press Releases
In The News
Events & Presentations
IMMX Investors Day
Stock Info
SEC Filings
Documents and Charters
Committees
Investor FAQ
Contact IR
Email Alerts
Contact
Overview
News & Events
Press Releases
In The News
Events & Presentations
Stock Information
Stock Quote & Chart
Historical Prices
Financials
SEC Filings
Governance
Management
Board of Directors
Documents and Charters
Committees
IR Resources
Investor FAQ
Contact IR
Email Alerts
Overview
News & Events
Press Releases
In The News
Events & Presentations
Stock Information
Stock Quote & Chart
Historical Prices
Financials
SEC Filings
Governance
Management
Board of Directors
Documents and Charters
Committees
IR Resources
Investor FAQ
Contact IR
Email Alerts
Email Alerts
You are subscribed. Thank you for your interest in Immix Biopharma, Inc.